We are live on ! Find out more
PFM

Privium Fund Management Portfolio holdings

AUM $544M
1-Year Est. Return 72.49%
This Fund
S&P 500
This Quarter Est. Return
+10.91%
1 Year Est. Return
+72.49%
3 Year Est. Return
+451.42%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$392M
AUM Growth
+$17.6M
Cap. Flow
+$3.68M
Cap. Flow %
0.94%
Top 10 Hldgs %
60.17%
Holding
139
New
22
Increased
37
Reduced
35
Closed
10
Avg Time Held
4.7 quarters
Top 10 Avg Time Held
5 quarters
Top 20 Avg Time Held
5 quarters

Top Buys

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$7.69M
2
ALXO icon
ALX Oncology
ALXO
+$4.88M
3
AMD icon
Advanced Micro Devices
AMD
+$4.75M
4
RARE icon
Ultragenyx Pharmaceutical
RARE
+$1.56M
5
ASTSW icon
AST SpaceMobile, Inc. Warrant
ASTSW
+$1.51M

Top Sells

Rank Stock Value
1
SPOT icon
Spotify
SPOT
+$6.02M
2
FUSN icon
Fusion Pharmaceuticals Inc. Common Shares
FUSN
+$5.35M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$3.37M
4
PTGX icon
Protagonist Therapeutics
PTGX
+$3.3M
5
MRNA icon
Moderna
MRNA
+$2.1M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 24.59%
2 Healthcare 24.36%
3 Technology 24.32%
4 Communication Services 14.32%
5 Miscellaneous 8.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
TSLA icon
1
Tesla
TSLA
$1.48T
$47.4M 12.09%
213,000
+44,000
+26% +$7.69M
2022 Q4
6 quarters
SPOT icon
2
Spotify
SPOT
$108B
$47.2M 12.04%
150,000
-20,000
-12% -$6.02M
2021 Q4
10 quarters
AMZN icon
3
Amazon
AMZN
$2.79T
$28M 7.15%
141,000
– –
2022 Q3
7 quarters
SHOP icon
4
Shopify
SHOP
$227B
$27.2M 6.93%
415,000
– –
2021 Q4
10 quarters
OXY.WS icon
5
Occidental Petroleum Corp Warrants
OXY.WS
$37.3B
$20.1M 5.13%
496,207
– –
2021 Q4
10 quarters
SNOW icon
6
Snowflake
SNOW
$126B
$18.4M 4.68%
129,000
– –
2021 Q4
10 quarters
SE icon
7
Sea Limited
SE
$58.8B
$14.7M 3.74%
210,000
– –
2023 Q2
4 quarters
PLTR icon
8
Palantir
PLTR
$501B
$11.5M 2.93%
445,000
– –
2023 Q2
4 quarters
IONS icon
9
Ionis Pharmaceuticals
IONS
$7.04B
$11.2M 2.85%
247,267
+20,274
+9% +$832K
2021 Q4
10 quarters
RARE icon
10
Ultragenyx Pharmaceutical
RARE
$1.47B
$10.3M 2.63%
251,602
+36,500
+17% +$1.56M
2021 Q4
10 quarters
PRQR icon
11
ProQR Therapeutics
PRQR
$209M
$9.21M 2.35%
5,580,725
+236,279
+4% +$459K
2021 Q4
10 quarters
DDOG icon
12
Datadog
DDOG
$102B
$8.66M 2.21%
65,993
– –
2022 Q4
6 quarters
ITCI icon
13
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$8.09M 2.06%
117,983
+9,100
+8% +$631K
2023 Q2
4 quarters
GOOGL icon
14
Alphabet (Google) Class A
GOOGL
$4.33T
$7.41M 1.89%
40,000
-20,000
-33% -$3.37M
2021 Q4
10 quarters
ARWR icon
15
Arrowhead Research
ARWR
$8.21B
$7.24M 1.85%
286,936
+13,000
+5% +$319K
2021 Q4
10 quarters
NVDA icon
16
NVIDIA
NVDA
$5.52T
$6.99M 1.78%
57,000
-3,000
-5% -$303K
2023 Q1
5 quarters
AMD icon
17
Advanced Micro Devices
AMD
$989B
$5.99M 1.53%
37,000
+29,500
+393% +$4.75M
2024 Q1
1 quarter
NET icon
18
Cloudflare
NET
$124B
$5.95M 1.52%
70,000
-5,000
-7% -$403K
2021 Q4
10 quarters
CRWD icon
19
CrowdStrike
CRWD
$267B
$5.88M 1.5%
60,000
– –
2021 Q4
10 quarters
AXSM icon
20
Axsome Therapeutics
AXSM
$8.19B
$5.87M 1.5%
74,332
-7,700
-9% -$570K
2023 Q1
5 quarters
MRK icon
21
Merck
MRK
$350B
$5.59M 1.43%
43,797
-1,700
-4% -$219K
2021 Q4
10 quarters
ROIV icon
22
Roivant Sciences
ROIV
$24.1B
$5.12M 1.3%
484,500
-83,295
-15% -$913K
2023 Q4
2 quarters
RCKT icon
23
Rocket Pharmaceuticals
RCKT
$252M
$4.96M 1.27%
250,980
+15,930
+7% +$366K
2022 Q2
8 quarters
ALNY icon
24
Alnylam Pharmaceuticals
ALNY
$29.9B
$4.8M 1.22%
19,393
-1,500
-7% -$237K
2023 Q3
3 quarters
MSFT icon
25
Microsoft
MSFT
$4.04T
$4.59M 1.17%
10,000
-400
-4% -$169K
2023 Q1
5 quarters
1
2 3 4 5

Similar funds

RWMH
Riverpoint Wealth Management Holdings Chicago, Illinois $544M AUM 20.39% 1-Year Est. Return
BPIA
Broad Peak Investment Advisers Singapore $544M AUM 132.56% 1-Year Est. Return
AFA
Abacus FCF Advisors Orlando, Florida $544M AUM 70.51% 1-Year Est. Return
TC
TownSquare Capital Provo, Utah $544M AUM 40.38% 1-Year Est. Return
FIM
FWL Investment Management Dallas, Texas $545M AUM 64.06% 1-Year Est. Return
DKAM
Drummond Knight Asset Management Crows Nest, NSW, Australia $545M AUM 73.62% 1-Year Est. Return
CCM
Coerente Capital Management Toronto, Ontario, Canada $543M AUM 7.53% 1-Year Est. Return
TI
Trigran Investments Northbrook, Illinois $545M AUM 56.2% 1-Year Est. Return

Privium Fund Management's Q2 2024 Portfolio in Review

As of Q2 2024, Privium Fund Management held 139 positions worth $392M, up 4.7% from $374M the previous quarter. Its ten largest holdings account for 60% of the portfolio.

Privium Fund Management's Q2 2024 filing shows 22 new, 37 increased, 35 reduced and 10 closed positions. Its largest new stake was ALX Oncology: 396,966 shares worth $2.27M. The largest sale was Spotify, an estimated $6.02M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 25% of assets, up from 19% a quarter earlier, followed by Healthcare and Technology.

  • Privium Fund Management's largest Q2 2024 buy was ALX Oncology: 396,966 shares worth $2.27M.
  • Privium Fund Management added most to Tesla in Q2 2024, an estimated $7.69M increase.
  • Privium Fund Management's biggest Q2 2024 reduction was Spotify, cutting an estimated $6.02M.
  • Privium Fund Management fully exited Fusion Pharmaceuticals Inc. Common Shares in Q2 2024, selling an estimated $5.35M.
  • Privium Fund Management's ten largest holdings make up 60% of its $392M portfolio in Q2 2024.
  • Privium Fund Management opened 22 new positions and closed 10 in Q2 2024.
  • Privium Fund Management's portfolio value rose 4.7% quarter-over-quarter to $392M.

Based on Privium Fund Management's 13F filing for Q2 2024, filed 1 Aug 2024.